Last reviewed · How we verify
Placebo ACCUHALER/DISKUS — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo ACCUHALER/DISKUS (Placebo ACCUHALER/DISKUS) — GlaxoSmithKline. Placebo contains no active pharmaceutical ingredient and produces no direct pharmacological effect.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo ACCUHALER/DISKUS TARGET | Placebo ACCUHALER/DISKUS | GlaxoSmithKline | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo ACCUHALER/DISKUS CI watch — RSS
- Placebo ACCUHALER/DISKUS CI watch — Atom
- Placebo ACCUHALER/DISKUS CI watch — JSON
- Placebo ACCUHALER/DISKUS alone — RSS
Cite this brief
Drug Landscape (2026). Placebo ACCUHALER/DISKUS — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-accuhaler-diskus. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing